UK Markets close in 2 hrs 25 mins

Genmab A/S (0MGB.L)

LSE - LSE Delayed price. Currency in DKK
Add to watchlist
2,581.26-9.88 (-0.38%)
As of 05:18PM GMT. Market open.
Currency in DKK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3N/A
S&P500 52-week change 3-10.17%
52-week high 32,574.00
52-week low 32,559.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 864.65M
% held by insiders 10.00%
% held by institutions 150.28%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin 37.83%
Operating margin (ttm)43.82%

Management effectiveness

Return on assets (ttm)14.56%
Return on equity (ttm)22.25%

Income statement

Revenue (ttm)14.6B
Revenue per share (ttm)223.21
Quarterly revenue growth (yoy)99.60%
Gross profit (ttm)14.6B
Net income avi to common (ttm)5.52B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-18.40%

Balance sheet

Total cash (mrq)22.32B
Total cash per share (mrq)341.49
Total debt (mrq)597M
Total debt/equity (mrq)2.17
Current ratio (mrq)15.57
Book value per share (mrq)419.77

Cash flow statement

Operating cash flow (ttm)3.91B
Levered free cash flow (ttm)2.09B